Jefferies Increases Price Target on Universal Health Svcs. (UHS)
Get Alerts UHS Hot Sheet
Price: $165.10 -0.48%
Rating Summary:
12 Buy, 16 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
12 Buy, 16 Hold, 2 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Jefferies analysts raised their price target on Universal Health Svcs. (NYSE: UHS) from $40 to $45, while maintaining their HOLD rating.
UHS reported worse than expect earnings this week, but the good news is that its FY12 EPS guidance of $4.33-$4.48 remains intact, says Jefferies analysts.
Universal Health Services operates 25 acute care hospitals and 206 behavioral health centers located in 37 states, Washington D.C., Puerto Rico and the U.S. Virgin Islands.
For an analyst ratings summary and ratings history on Universal Health Services click here. For more ratings news on Universal Health Services click here.
Shares of Universal Health Services closed at $43.45 yesterday.
UHS reported worse than expect earnings this week, but the good news is that its FY12 EPS guidance of $4.33-$4.48 remains intact, says Jefferies analysts.
Universal Health Services operates 25 acute care hospitals and 206 behavioral health centers located in 37 states, Washington D.C., Puerto Rico and the U.S. Virgin Islands.
For an analyst ratings summary and ratings history on Universal Health Services click here. For more ratings news on Universal Health Services click here.
Shares of Universal Health Services closed at $43.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MarineMax (HZO) PT Lowered to $35 at Stifel
- First Cash Financial (FCFS) PT Lowered to $140 at TD Cowen
- Teradyne (TER) PT Raised to $125 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS View, Analyst PT ChangeRelated Entities
Jefferies & Co, Raising Prices, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!